ZA846211B - Chromone alkaloid,a process for its isolation from dysoxylum binectariferum,and its use as a medicament - Google Patents

Chromone alkaloid,a process for its isolation from dysoxylum binectariferum,and its use as a medicament

Info

Publication number
ZA846211B
ZA846211B ZA846211A ZA846211A ZA846211B ZA 846211 B ZA846211 B ZA 846211B ZA 846211 A ZA846211 A ZA 846211A ZA 846211 A ZA846211 A ZA 846211A ZA 846211 B ZA846211 B ZA 846211B
Authority
ZA
South Africa
Prior art keywords
medicament
isolation
dysoxylum binectariferum
chromone
alkaloid
Prior art date
Application number
ZA846211A
Other languages
English (en)
Inventor
Sujata Vasudev Bhat
Virbala Shah
Alihussein Nomanbha Dohadwalla
Sadashiv Shantaram Mandrekar
Noel John De Souza
Gerhard Dickneite
Roland Kurrle
Hans-Ulrich Schorlemmer
Hans-Herald Sedlacek
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of ZA846211B publication Critical patent/ZA846211B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pain & Pain Management (AREA)
  • Transplantation (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
ZA846211A 1983-08-12 1984-08-10 Chromone alkaloid,a process for its isolation from dysoxylum binectariferum,and its use as a medicament ZA846211B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19833329186 DE3329186A1 (de) 1983-08-12 1983-08-12 Chromonalkaloid, verfahren zu seiner isolierung aus dysoxylum binectariferum, und seine verwendung als arzneimittel

Publications (1)

Publication Number Publication Date
ZA846211B true ZA846211B (en) 1985-03-27

Family

ID=6206424

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA846211A ZA846211B (en) 1983-08-12 1984-08-10 Chromone alkaloid,a process for its isolation from dysoxylum binectariferum,and its use as a medicament

Country Status (6)

Country Link
US (1) US4603137A (fr)
EP (1) EP0137193A3 (fr)
JP (1) JPS6058977A (fr)
DE (1) DE3329186A1 (fr)
DK (1) DK388484A (fr)
ZA (1) ZA846211B (fr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN164232B (fr) * 1986-04-11 1989-02-04 Hoechst India
DE3836676A1 (de) * 1988-10-28 1990-05-03 Hoechst Ag Die verwendung von 4h-1-benzopyran-4-on-derivaten, neue 4h-1-benzopyran-4-on-derivate und diese enthaltende arzneimittel
US5284856A (en) * 1988-10-28 1994-02-08 Hoechst Aktiengesellschaft Oncogene-encoded kinases inhibition using 4-H-1-benzopyran-4-one derivatives
EP0508347A1 (fr) * 1991-04-10 1992-10-14 Hoechst Aktiengesellschaft 5,7-dihydroxy-2-méthyl-8-[4-(3-hydroxy-1-(1-propyl))pipéridinyl]4H-1-benzopyran-4-one, sa préparation et son utilisation
US5733920A (en) * 1995-10-31 1998-03-31 Mitotix, Inc. Inhibitors of cyclin dependent kinases
US5849733A (en) * 1996-05-10 1998-12-15 Bristol-Myers Squibb Co. 2-thio or 2-oxo flavopiridol analogs
AU767241B2 (en) * 1998-09-14 2003-11-06 Qiang Xu Immunosuppressive agents
DE10113513A1 (de) * 2001-03-20 2002-10-02 Medinnova Ges Med Innovationen Kombinationspräparat zur Prophylaxe und/oder Therapie von Nervenzell- und/oder Gliazellschäden durch ein neues Behandlungsverfahren
CA2571710A1 (fr) 2004-06-24 2006-11-02 Nicholas Valiante Immuno-potentialisateurs a petites molecules et analyses visant a detecter leur presence
BRPI0402875A (pt) 2004-07-21 2006-03-07 Fundacao Oswaldo Cruz composições medicamentosas à base de extrato de carapa guianensis e/ou dos compostos quìmicos isolados desse extrato
JP2008255008A (ja) * 2005-07-19 2008-10-23 Tokyo Medical & Dental Univ 滑膜細胞増殖抑制剤
US9018006B2 (en) 2010-07-23 2015-04-28 The University Of Toledo Stable Tregs and related materials and methods
WO2018094275A1 (fr) 2016-11-18 2018-05-24 Tolero Pharmaceuticals, Inc. Promédicaments de l'alvocidib et leur utilisation en tant qu'inhibiteurs de protéines kinases
US11497756B2 (en) 2017-09-12 2022-11-15 Sumitomo Pharma Oncology, Inc. Treatment regimen for cancers that are insensitive to BCL-2 inhibitors using the MCL-1 inhibitor alvocidib
KR20210099066A (ko) 2018-12-04 2021-08-11 스미토모 다이니폰 파마 온콜로지, 인크. 암의 치료를 위한 작용제로서 사용하기 위한 cdk9 억제제 및 그의 다형체
JP2022525149A (ja) 2019-03-20 2022-05-11 スミトモ ダイニッポン ファーマ オンコロジー， インコーポレイテッド ベネトクラクスが失敗した急性骨髄性白血病（ａｍｌ）の処置

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB882537A (en) * 1958-09-12 1961-11-15 Recordati Lab Farmacologico S Chromones and processes for the preparation thereof
GB1147976A (en) * 1965-12-21 1969-04-10 Fisons Pharmaceuticals Ltd Chromone derivatives

Also Published As

Publication number Publication date
DK388484A (da) 1985-02-13
JPS6058977A (ja) 1985-04-05
EP0137193A2 (fr) 1985-04-17
DK388484D0 (da) 1984-08-10
EP0137193A3 (fr) 1987-02-04
US4603137A (en) 1986-07-29
DE3329186A1 (de) 1985-02-21

Similar Documents

Publication Publication Date Title
ZA83743B (en) Pyrazolooxazines,pyrazolothiazines,and pyrazoloquinolines,process for their preparation and their use as medicaments
ZA881865B (en) Substituted 9-amino-tetrahydroacridines and related compounds,a process for their preparation and their use as medicaments
PT84806A (en) Process for preparing benzopyrans
ZA846211B (en) Chromone alkaloid,a process for its isolation from dysoxylum binectariferum,and its use as a medicament
PL256373A1 (en) Process for preparing silibinin,free of isosilibin
IL71856A0 (en) Dibenzodiazepin derivatives,a process for their preparation and their use as medicaments
IL83152A0 (en) 7-acyloxy-6-aminoacyloxypolyoxylabdanes,a process for their preparation,and their use as medicaments
CS309984A2 (en) Process for preparing pharmaceutical agent
ZA841183B (en) Biscarboxamides for combating diseases,and processes for their preparation
DE3173613D1 (en) 7-oxo-cephalosporins and 6-oxo-penicillins, their analogues and process for their preparation
DE3463041D1 (en) Tributylphenolether-glycidyl-sulphonates, process for their preparation and their use
ZA83592B (en) Corynantheine derivatives,processes for their preparation,and their use
EP0098620A3 (en) Alpha,beta-dihydropolyprenyl derivatives and a process for preparing these derivatives
ZA813935B (en) Indene derivatives,processes for their preparation,and their use as medicaments
GR80474B (en) Chinazolinderivatives, method for the preparation thereof, and medicaments containing said compounds
DE3364376D1 (en) Isoindolazines, process for their preparation and their use
ZA846580B (en) 16-fluoro-16,17-didehydro-prostanoids and process for their preparation
DE3367598D1 (en) 14-amino-steroid derivatives, their therapeutical use and process for their preparation
ZA833240B (en) Titanium-containing zeolites,a process for their preparation and their use
DE3371509D1 (en) Clavulone derivatives, process for preparing the same, and use of said compounds
ZA856775B (en) Histargin-related compounds,a process for their preparation and their use as medicaments
EP0121228A3 (en) Lipotensides, process for their isolation and their use
ZA825239B (en) Oxothienobenzoxepins,a method for their preparation and their use as medicaments
DE3465992D1 (en) Process for the preparation of alpha-tocopherol
ZA827368B (en) Substituted 6-phenoxypyrid-2-ylmethyl-vinylcyclopropanecarboxylates,a process for their preparation,and their use as pest-combating agents